mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.008 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.009 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |